A new epilepsy treatment from Belgian drugmaker UCB helped reduce the rate of seizures in a Phase III trial, the company said, setting the stage for an FDA application and a shot at widening its footprint in the field.

…read more

Source: UCB inches toward the FDA with its latest epilepsy contender


0 No comments